Latest filing published 05 May 2026 for AMGEN INC, €182k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jonathan P. Graham on record concern Amgen Inc, in the capacity of senior executive. The record holds 35 filings, for trades running from 30 April 2021 to 2 May 2026.
No open-market purchase appears, only 2 sales worth €5.6M. Besides market trades, the filings include 30 share grants and 1 option exercise.
The record was last updated on 5 May 2026 with a share grant (€182k) in Amgen Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations